hemodialysis

Open Access
SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients
Sushma Shankar, Joseph Beckett, Tom Tipton, Ane Ogbe, Mwila Kasanyinga, Christina Dold, Sheila Lumley, Fungai Dengu, Gianluca Rompianesi, Faysal Elgilani, Stephanie Longet, Alexandra Deeks, Rebecca P. Payne, Christopher J.A. Duncan, Alex Richter, Thushan I. de Silva, Lance Turtle, Katherine Bull, Martin Barnardo, Peter J. Friend, Susanna J. Dunachie, Joanna Hester, Fadi Issa, Eleanor Barnes, Miles W. Carroll and Paul Klenerman

JASN May 2022, 33 (5) 883-887; DOI: https://doi.org/10.1681/ASN.2021121587

Add to Selected Citations
Open Access
Confirmed Drop in Treatment of Patients with Incident End-Stage Kidney Disease During the Novel Coronavirus Disease 2019 Pandemic
Lucas Jacobs, Arnaud Devresse, Thomas Baudoux and Frédéric Collart

JASN February 2022, 33 (2) 455; DOI: https://doi.org/10.1681/ASN.2021101296

Add to Selected Citations
You have accessRestricted Access
Patient Health Outcomes following Dialysis Facility Closures in the United States
Jingbo Niu, Maryam K. Saeed, Wolfgang C. Winkelmayer and Kevin F. Erickson

JASN October 2021, 32 (10) 2613-2621; DOI: https://doi.org/10.1681/ASN.2021020244

Add to Selected Citations
Open Access
Hemodialysis Patients Make Long-Lived Antibodies against SARS-CoV-2 that May Be Associated with Reduced Reinfection
Gemma D. Banham, Alexandra Godlee, Sian E. Faustini, Adam F. Cunningham, Alex Richter, Lorraine Harper and on behalf of the COVID-HD Birmingham Study Group

JASN September 2021, 32 (9) 2140-2142; DOI: https://doi.org/10.1681/ASN.2021020188

Add to Selected Citations
Open Access
Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients
Dominique Bertrand, Mouad Hamzaoui, Veronique Lemée, Julie Lamulle, Mélanie Hanoy, Charlotte Laurent, Ludivine Lebourg, Isabelle Etienne, Mathilde Lemoine, Frank Le Roy, Dorian Nezam, Jean-Christophe Plantier, Olivier Boyer, Dominique Guerrot and Sophie Candon

JASN September 2021, 32 (9) 2147-2152; DOI: https://doi.org/10.1681/ASN.2021040480

Add to Selected Citations
You have accessRestricted Access
Authors’ Reply
An S. De Vriese

JASN September 2021, 32 (9) 2390-2391; DOI: https://doi.org/10.1681/ASN.2021060866

Add to Selected Citations
Open Access
Antibody Status, Disease History, and Incidence of SARS-CoV-2 Infection Among Patients on Chronic Dialysis
Dena E. Cohen, Scott Sibbel, Gilbert Marlowe, Kelsey Bludorn, Dawn Miller, Tara Kelley, Jeffrey Connaire, Amy Young, Francesca Tentori and Steven M. Brunelli

JASN August 2021, 32 (8) 1880-1886; DOI: https://doi.org/10.1681/ASN.2021030387

Add to Selected Citations
Open Access
Racial and Neighborhood-Level Disparities in COVID-19 Incidence among Patients on Hemodialysis in New York City
Sri Lekha Tummalapalli, Jeffrey Silberzweig, Daniel Cukor, Jonathan T. Lin, Tarek Barbar, Yao Liu, Kwan Kim, Thomas S. Parker, Daniel M. Levine and Said A. Ibrahim

JASN August 2021, 32 (8) 2048-2056; DOI: https://doi.org/10.1681/ASN.2020111606

Add to Selected Citations
You have accessRestricted Access
Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial
An S. De Vriese, Rogier Caluwé, Hans Van Der Meersch, Koen De Boeck and Dirk De Bacquer

JASN June 2021, 32 (6) 1474-1483; DOI: https://doi.org/10.1681/ASN.2020111566

Add to Selected Citations
Open Access
Kinetics of Anti–SARS-CoV-2 IgG Antibodies in Hemodialysis Patients Six Months after Infection
Hamza Sakhi, Djamal Dahmane, Philippe Attias, Thomas Kofman, Magali Bouvier, Nathanael Lapidus, Slim Fourati, Khalil El Karoui and Mondor NephroCov Study Group

JASN May 2021, 32 (5) 1033-1036; DOI: https://doi.org/10.1681/ASN.2020111618

Add to Selected Citations

Main menu

User menu

Search

hemodialysis

Pages

Articles

Information for Authors

About

Journal Information

More Information